B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 103
Growth YoY: +3.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 2,751–2,800 of 2,959 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00003505	Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma	withdrawn	Phase 2	0	Burzynski Research InstituteOTHER	1	Jul 10, 2013	clinicaltrials
NCT00085345	Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma	withdrawn	Phase 2	0	OncotherapeuticsINDUSTRY	1	Jul 10, 2013	clinicaltrials